Endothelial Protein C Receptor in Prostate Cancer Cells
Author Information
Author(s): Mario Menschikowski, Albert Hagelgans, Oliver Tiebel, Ludwig Klinsmann, Graeme Eisenhofer, Gabriele Siegert
Primary Institution: Institute of Clinical Chemistry and Laboratory Medicine, Technical University of Dresden
Hypothesis
The study aims to analyze the expression, cell surface exposition, and shedding of endothelial protein C receptor (EPCR) in normal and malignant prostate cell lines.
Conclusion
The study demonstrates significant differences in the expression and shedding of EPCR in prostate cancer cell lines compared to normal cells, which may be important for understanding its role in cancer.
Supporting Evidence
- EPCR expression is higher in invasive prostate cancer cells compared to normal cells.
- Pharmacological agents can induce the release of soluble EPCR in prostate cells.
- IL-1β and TNF-α significantly increase sEPCR release in certain prostate cancer cell lines.
Takeaway
This study found that prostate cancer cells have more of a certain protein (EPCR) on their surface than normal cells, which might help the cancer grow.
Methodology
The study used flow cytometry, ELISA, and various pharmacological agents to analyze EPCR expression and shedding in prostate cell lines.
Limitations
The study primarily focuses on in vitro cell lines, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website